# FDA Inspection 1282322 - Watson Pharma Private Ltd. - July 25, 2025

Source: https://www.keypedia.com/records/fda_inspections/watson-pharma-private-ltd/541ce75e-5dfe-46d3-bf7d-dd8544c9a253
Source feed: FDA_Inspections

> FDA Inspection 1282322 for Watson Pharma Private Ltd. on July 25, 2025. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1282322
- Company Name: Watson Pharma Private Ltd.
- Inspection Date: 2025-07-25
- Classification: No Action Indicated (NAI)
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1282322 - 2025-07-25](https://www.keypedia.com/records/fda_inspections/watson-pharma-private-ltd/ec81ff3d-eaf3-4f9d-9acc-013a9c57b8e0)
- [FDA Inspection 1177794 - 2022-07-29](https://www.keypedia.com/records/fda_inspections/watson-pharma-private-ltd/674b4fe7-38fe-4e7c-9d1d-25716dc09266)
- [FDA Inspection 1109471 - 2019-09-13](https://www.keypedia.com/records/fda_inspections/watson-pharma-private-ltd/4607d638-142a-4813-967b-9fbd438d15f9)
- [FDA Inspection 1100283 - 2019-08-23](https://www.keypedia.com/records/fda_inspections/watson-pharma-private-ltd/448ad421-0bd9-4d5a-8109-44ab5f78d44f)

Company: https://www.keypedia.com/companies/watson-pharma-private-ltd/044a6129-9d35-4487-9ba4-70083b6e2e10

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c